HRT Alternatives: 6 Non-Hormonal Options Compared (2026)
Medically reviewed by Medical Advisory Board Last reviewed 2026-07-13
What to consider for menopause symptoms if you can't or don't want to use hormone therapy
For women who can't or choose not to use hormone therapy, the strongest non-hormonal alternatives are two newly approved NK-receptor drugs — fezolinetant (Veozah) and elinzanetant (Lynkuet) — plus SSRIs/SNRIs, cognitive behavioral therapy (CBT-I/CBT), and lifestyle measures. Each targets different symptoms with different evidence strength, and several can be combined.
This article is for informational purposes only and is not medical advice. Consult a physician before starting, stopping, or switching any prescription medication, particularly if you have a history of hormone-sensitive cancer.
Hormone therapy (HRT, also called menopausal hormone therapy or MHT) is the most effective treatment for hot flashes and several other menopause symptoms, but it isn't right or accessible for everyone — a history of certain cancers, blood clots, personal preference, or simply not tolerating it are all common reasons women look for alternatives. Two new non-hormonal prescription drugs approved in late 2025 have meaningfully expanded the realistic options. This roundup ranks them alongside established non-drug approaches. For a breakdown of hormone therapy types themselves, see our bioidentical hormones vs HRT comparison, and for the broader symptom picture, see our menopause hub.
Want expert help with your hormone health?
We can match you with a board-certified hormone specialist who understands this area — so you get the right doctor, not just any doctor.
Book An Appointment With A Specialist →HRT Alternatives Ranked
The two newest prescription options target hot flashes specifically and directly; the rest work through different mechanisms or address a broader symptom picture. The table compares each option, with HRT included as the baseline.| Option | Type | Best For | Evidence Strength |
|---|---|---|---|
| Hormone therapy (HRT/MHT) — baseline | Estrogen ± progesterone | Most effective overall for hot flashes and several other symptoms | Strongest; decades of RCT data |
| Fezolinetant (Veozah) | NK3 receptor antagonist, oral, non-hormonal | Moderate-to-severe hot flashes; hormone-sensitive cancer history | FDA-approved 2023; SKYLIGHT Phase 3 trials, ~2,800 patients |
| Elinzanetant (Lynkuet) | Dual NK1/NK3 receptor antagonist, oral, non-hormonal | Moderate-to-severe hot flashes, especially with sleep disruption | FDA-approved Oct 2025; OASIS-3 trial showed >73% VMS reduction at 12 weeks |
| SSRIs/SNRIs (e.g. escitalopram, venlafaxine, paroxetine/Brisdelle) | Antidepressant class, repurposed | Hot flashes plus co-occurring anxiety or mood symptoms | Multiple RCTs; paroxetine (Brisdelle) is FDA-approved specifically for hot flashes |
| CBT / CBT-I | Structured behavioral therapy, no medication | Sleep, anxiety, and hot-flash interference — no drug interactions or contraindications | Tier-1 evidence (Ayers et al. 2012; Kalmbach et al. 2019) |
| Lifestyle measures (layering, cooling, trigger avoidance, exercise) | No drug | Mild symptoms or as a foundation under any other option | Modest on its own; supportive alongside other treatments |
Fezolinetant (Veozah): The First NK3 Antagonist
Best for: moderate-to-severe hot flashes, including women with a hormone-sensitive cancer history. Veozah (fezolinetant) was the first neurokinin-3 (NK3) receptor antagonist approved for hot flashes, in May 2023. It works by blocking an NK3 receptor pathway in the brain involved in the body's temperature-regulation signaling that goes awry during menopause — a mechanism entirely separate from estrogen, so it carries no estrogen-related contraindication. It's taken as a once-daily oral tablet, with efficacy established across the SKYLIGHT Phase 3 trial program of roughly 2,800 patients.
Elinzanetant (Lynkuet): The Newest Dual-Receptor Option
Best for: moderate-to-severe hot flashes, especially with sleep disruption. Lynkuet (elinzanetant) was FDA-approved in October 2025 as the first dual NK1/NK3 receptor antagonist, adding a second receptor target to fezolinetant's mechanism. Its OASIS-3 trial reported more than a 73% reduction in moderate-to-severe hot flash frequency at 12 weeks versus 47% for placebo, with reported improvements in sleep quality as well. Like fezolinetant, it is oral, taken once daily, and non-hormonal.
SSRIs and SNRIs: The Established Antidepressant Route
Best for: hot flashes with co-occurring anxiety or mood symptoms. Before the NK-antagonist class existed, certain antidepressants were the main non-hormonal prescription route. Low-dose paroxetine (Brisdelle) holds an FDA approval specifically for hot flashes; escitalopram and venlafaxine have randomized trial support and are often chosen when anxiety or mood symptoms accompany the hot flashes. These can also be a reasonable first step for women already on an SSRI/SNRI for another reason.
Cognitive Behavioral Therapy (CBT/CBT-I): The Drug-Free Option
Best for: sleep disruption and anxiety alongside hot flashes, or as a layer under any medication on this list. Cognitive behavioral therapy — including CBT-I for sleep specifically — has tier-1 evidence for menopausal symptoms broadly, improving hot-flash interference, sleep, mood, and anxiety with effects that hold up at 6-month follow-up in randomized trials. It carries no drug interactions or dosing risk, which makes it a reasonable layer under any other option on this list, not just a standalone choice. See our perimenopause anxiety guide for the trial-level detail behind the SSRI/SNRI and CBT evidence above.
Lifestyle Measures: The Foundation Layer
Best for: mild symptoms, or as a base layer under any drug or therapy above. Layered clothing, cooling strategies, identifying personal hot-flash triggers (alcohol, spicy food, caffeine), and regular exercise produce modest effects on their own but are free of side effects and support whatever else you add. They rarely resolve moderate-to-severe symptoms alone, which is why they work best alongside — not instead of — a medication or CBT.
How These Compare to HRT Directly
Hormone therapy still produces the largest average reduction in hot flash frequency and severity of any option here, and it also addresses bone density and some other menopause-related changes that non-hormonal options don't touch. The NK-antagonist drugs come closest on hot-flash-specific efficacy in their own trials, though direct head-to-head trials against HRT are limited. The practical decision usually comes down to why HRT isn't an option (medical contraindication vs. preference) more than a pure efficacy comparison — someone with a hormone-sensitive cancer history has real medical reasons to prefer a non-hormonal route regardless of the efficacy gap.
The Bottom Line on HRT Alternatives
Fezolinetant and elinzanetant are the strongest non-hormonal options for hot flashes specifically; SSRIs/SNRIs are a reasonable route when mood symptoms overlap; CBT is evidence-based and combinable with anything else on this list; and lifestyle measures are a foundation, not a standalone fix, for moderate-to-severe symptoms. Take the free assessment to map your hormone and menopause symptoms before choosing a direction with your doctor.
Frequently Asked Questions
What is the best non-hormonal alternative to HRT?
For hot flashes specifically, the two newest options — fezolinetant (Veozah) and elinzanetant (Lynkuet) — have the strongest recent trial evidence among non-hormonal drugs. SSRIs/SNRIs and CBT are established alternatives, especially when anxiety or sleep symptoms overlap. The best choice depends on your specific symptoms and why HRT isn't an option for you.
Is there a new non-hormonal drug for hot flashes in 2026?
Yes. Elinzanetant (brand name Lynkuet) was FDA-approved in October 2025 as the first dual NK1/NK3 receptor antagonist for moderate-to-severe hot flashes, joining fezolinetant (Veozah, approved 2023) as the two newest non-hormonal prescription options.
Can I take a non-hormonal option if I've had breast cancer?
Fezolinetant, elinzanetant, SSRIs/SNRIs, and CBT are all non-hormonal and don't carry the estrogen-related contraindications that make HRT unsuitable for many women with a history of hormone-sensitive breast cancer. Always confirm any specific medication choice with your oncologist and prescriber given individual cancer history.
Does CBT actually help with hot flashes?
Yes. Randomized controlled trials, including a landmark study by Ayers et al. (2012), found CBT significantly improved hot flash interference, sleep, mood, and anxiety, with benefits maintained at 6-month follow-up. It has no drug interactions and can be combined with medication-based options.
Why would someone choose a non-hormonal option over HRT?
Common reasons include a history of hormone-sensitive cancer, blood clot risk, personal preference to avoid hormones, or not tolerating HRT's side effects. HRT still produces the largest average symptom reduction for most women, so the choice is usually driven by medical contraindications or preference rather than efficacy alone.
Topic updates
Get the weekly hormone optimization roundup
Testosterone, thyroid, cortisol, estrogen, menopause, perimenopause, libido, and hormone testing.
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Continue Reading
← Back to Hormone Optimization
-
Menopause, Fatigue, Weight Gain, and Metabolic Health
Menopause symptoms, body composition, testing, and treatment paths.
-
Perimenopause Symptoms, Fatigue, and Early Hormone Changes
Early-transition fatigue, weight gain, sleep disruption, and symptom triage.
-
Low Testosterone in Men: Symptoms, Causes, and Treatment
Symptoms, causes, and treatment options for low T in men.
-
Hormone Imbalance: Symptoms, Causes, and How to Fix It
How hormonal imbalances present differently in men and women.
-
Thyroid Symptoms: Hypothyroidism vs Hyperthyroidism and What Your Labs Mean
Hypothyroidism vs hyperthyroidism — symptoms and what labs reveal.
-
High Cortisol Symptoms: Signs Your Stress Hormones Are Too High
Chronic stress signs: weight gain, insomnia, anxiety, impaired recovery.
-
Perimenopause Symptoms: the Complete Guide
The complete symptom list — hot flashes affect ~80% of women.
-
Perimenopause Fatigue: Causes and Energy Solutions
Why perimenopause causes fatigue and what to do about it.
-
Brain Fog: Hormonal Causes and How to Clear It
Hormonal causes of cognitive sluggishness — thyroid, cortisol, estrogen.
-
What Causes Low Testosterone? Root Causes Explained
Root causes: age, obesity, sleep, medications, chronic illness.